- 米国企業
- HUMANA INC
HUMANA INCHUM
時価総額
$1950.4億
PER
| 2010年 12月31日 | 2012年 12月31日 | 2013年 12月31日 | 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | |
| Net income | - | - | - | - | - | - | - | - | - | - | 2,934 | 2,802 | 2,484 |
| Gain on sale of Gentiva Hospice | - | - | - | - | 270 | - | - | -786 | - | - | - | 237 | - |
| Loss on investment securities, net | - | - | - | - | - | - | - | - | - | 838 | -130 | -205 | -54 |
| Gain on Kindred at Home equity method investment | - | - | - | - | - | - | - | - | - | - | 1,129 | - | - |
| Equity in net losses (earnings) | - | - | - | - | - | - | - | 11 | 14 | 74 | 65 | -4 | -63 |
| Stock-based compensation | 63 | 82 | 92 | 98 | 109 | 115 | 157 | 137 | 163 | 181 | 180 | 216 | 175 |
| Depreciation | - | - | - | - | - | - | - | - | 505 | 528 | 640 | 749 | 850 |
| Amortization | - | - | - | - | 93 | 77 | 75 | 90 | - | - | 73 | 96 | 67 |
| Tangible Asset Impairment Charges | - | - | - | - | - | - | - | - | - | - | - | 248 | 206 |
| Deferred Income Tax Expense (Benefit) | - | - | - | - | - | - | - | - | 162 | 195 | 15 | -100 | -164 |
| Impairment of indefinite-lived intangible assets | - | - | - | - | - | - | - | - | - | - | - | - | 55 |
| Receivables | 46 | -326 | 251 | 264 | 180 | 158 | -406 | 200 | 32 | 85 | 280 | 54 | 337 |
| Other assets | -81 | 253 | 330 | 952 | 872 | -426 | 582 | 484 | -118 | 581 | 491 | 463 | 1,318 |
| Benefits payable | 247 | -41 | 109 | 582 | 501 | -413 | 105 | 252 | 1,142 | 2,139 | 104 | 975 | 915 |
| Other liabilities | 722 | 300 | 313 | 413 | -129 | 937 | 641 | -676 | 471 | 599 | 176 | 44 | 841 |
| Unearned revenues | - | - | - | - | - | - | - | -95 | -36 | 71 | -65 | 32 | -20 |
| Deferred income taxes | - | - | - | - | - | - | - | - | - | - | - | - | -167 |
| Other, net | - | - | - | - | - | - | - | - | 90 | 49 | 40 | 70 | 113 |
| Receivables | 46 | -326 | 251 | 264 | 180 | 158 | -406 | 200 | 32 | 85 | 280 | 54 | 337 |
| Other assets | -81 | 253 | 330 | 952 | 872 | -426 | 582 | 484 | -118 | 581 | 491 | 463 | 1,318 |
| Benefits payable | 247 | -41 | 109 | 582 | 501 | -413 | 105 | 252 | 1,142 | 2,139 | 104 | 975 | 915 |
| Other liabilities | 722 | 300 | 313 | 413 | -129 | 937 | 641 | -676 | 471 | 599 | 176 | 44 | 841 |
| Unearned revenues | - | - | - | - | - | - | - | -95 | -36 | 71 | -65 | 32 | -20 |
| Other, net | - | - | - | - | - | - | - | - | 90 | 49 | 40 | 70 | 113 |
| Net cash provided by operating activities | 2,242 | 1,923 | 1,716 | 1,618 | 868 | 1,936 | 4,051 | 2,173 | 5,284 | 5,639 | 2,262 | 4,587 | 3,981 |
| Proceeds from sale of Gentiva Hospice, net | - | - | - | - | - | - | - | - | - | - | - | 2,701 | - |
| Acquisitions, net of cash and cash equivalents acquired | 832 | 1,235 | 187 | 18 | 38 | 7 | 31 | 354 | - | 709 | 4,187 | 337 | 233 |
| Purchases of property and equipment | 222 | 410 | 441 | 528 | 523 | 527 | 526 | 612 | 736 | 964 | 1,316 | 1,120 | 1,004 |
| Purchases of investment securities | 4,589 | 3,221 | 3,261 | 2,883 | 6,739 | 6,566 | 6,265 | 4,687 | 6,361 | 9,125 | 7,197 | 6,049 | 7,552 |
| Proceeds from sale of property and equipment | 0 | - | 4 | - | 1 | - | 2 | - | - | - | - | - | 210 |
| Maturities of investment securities | 1,750 | 1,497 | 1,077 | 885 | 1,065 | 1,426 | 1,111 | 972 | 1,733 | 4,986 | 2,597 | 1,365 | 1,292 |
| Purchases of investment securities | 4,589 | 3,221 | 3,261 | 2,883 | 6,739 | 6,566 | 6,265 | 4,687 | 6,361 | 9,125 | 7,197 | 6,049 | 7,552 |
| Proceeds from sales of investment securities | 2,012 | 1,404 | 1,592 | 2,409 | 5,493 | 4,312 | 2,768 | 3,494 | 4,086 | 2,747 | 3,547 | 2,434 | 3,795 |
| Maturities of investment securities | 1,750 | 1,497 | 1,077 | 885 | 1,065 | 1,426 | 1,111 | 972 | 1,733 | 4,986 | 2,597 | 1,365 | 1,292 |
| Net cash used in investing activities | -1,811 | -1,965 | -1,182 | -63 | 320 | -1,362 | -2,941 | -3,087 | -1,278 | -3,065 | -6,556 | -1,006 | -3,492 |
| Proceeds from sales of investment securities | 2,012 | 1,404 | 1,592 | 2,409 | 5,493 | 4,312 | 2,768 | 3,494 | 4,086 | 2,747 | 3,547 | 2,434 | 3,795 |
| Net cash used in investing activities | -1,811 | -1,965 | -1,182 | -63 | 320 | -1,362 | -2,941 | -3,087 | -1,278 | -3,065 | -6,556 | -1,006 | -3,492 |
| Receipts (withdrawals) from contract deposits, net | - | - | - | - | - | - | - | - | - | - | 306 | -1,993 | -828 |
| Proceeds from issuance of senior notes, net | - | 990 | - | 1,733 | - | - | 1,779 | - | 987 | 1,088 | 2,984 | 1,982 | 2,544 |
| Repayment of senior notes | - | - | - | - | - | - | - | - | - | 400 | - | 1,000 | 1,832 |
| Proceeds from (Repayments of) Commercial Paper | - | - | - | - | - | -2 | -153 | 485 | -360 | - | 352 | -376 | 211 |
| Proceeds from term loan | - | - | - | - | - | - | - | - | - | 1,000 | 2,500 | - | - |
| Proceeds from Short-Term Debt | - | - | - | - | - | - | - | 1,000 | - | - | - | - | 100 |
| Repayment of term loan | - | - | - | - | - | - | - | - | 650 | 1,000 | 2,078 | 2,000 | - |
| Repayment of short-term borrowings | - | - | - | - | - | - | - | 350 | - | - | - | - | 100 |
| Debt issue costs | 8 | - | - | - | - | - | - | - | - | - | 31 | 6 | 7 |
| Common stock repurchases | 109 | 518 | 531 | 872 | 385 | 104 | 3,365 | 1,090 | 1,070 | 1,820 | 79 | 2,096 | 1,573 |
| Repayment of term loan | - | - | - | - | - | - | - | - | - | - | - | - | 500 |
| Dividends paid | - | 165 | 168 | 172 | 172 | 177 | 220 | 265 | 291 | 323 | 354 | 392 | 431 |
| Debt issue costs | 8 | - | - | - | - | - | - | - | - | - | 31 | 6 | 7 |
| Change in book overdraft | - | 18 | 79 | -69 | -33 | -89 | -71 | 30 | 54 | 95 | 6 | -28 | 55 |
| Common stock repurchases | 109 | 518 | 531 | 872 | 385 | 104 | 3,365 | 1,090 | 1,070 | 1,820 | 79 | 2,096 | 1,573 |
| Other, net | - | - | - | - | - | - | - | - | - | - | - | 9 | -151 |
| Dividends paid | - | 165 | 168 | 172 | 172 | 177 | 220 | 265 | 291 | 323 | 354 | 392 | 431 |
| Net cash (used in) provided by financing activities | -371 | -29 | -702 | -758 | -552 | 732 | -945 | -785 | -2,295 | -1,955 | 3,015 | -1,914 | -856 |
| Change in book overdraft | - | 18 | 79 | -69 | -33 | -89 | -71 | 30 | 54 | 95 | 6 | -28 | 55 |
| Other, net | - | - | - | - | - | - | - | - | - | - | - | 9 | -151 |
| Net cash (used in) provided by financing activities | -371 | -29 | -702 | -758 | -552 | 732 | -945 | -785 | -2,295 | -1,955 | 3,015 | -1,914 | -856 |
| (Decrease) increase in cash and cash equivalents | - | - | - | - | - | - | - | - | 1,711 | 619 | -1,279 | 1,667 | -367 |
| Interest payments | - | - | - | - | - | - | - | 195 | 212 | 258 | 285 | 354 | 394 |
| Income Taxes Paid, Net | 785 | 745 | 734 | 1,030 | 1,179 | 916 | 1,498 | 631 | 518 | 1,132 | 227 | 758 | 997 |
| Fair Value of Assets Acquired | 1,043 | 1,535 | 196 | 18 | 38 | 7 | 31 | 392 | 28 | 819 | 9,804 | 460 | 462 |
| Less: Fair value of liabilities assumed | - | 300 | 9 | - | - | - | - | 38 | 28 | 110 | 3,235 | 70 | 234 |
| Less: Noncontrolling interests acquired | - | - | - | - | - | - | - | - | - | - | 22 | 53 | -5 |
| Less: Remeasured existing Kindred at Home equity method investment | - | - | - | - | - | - | - | - | - | - | 2,360 | - | - |
| Payments to Acquire Businesses, Net of Cash Acquired | 832 | 1,235 | 187 | 18 | 38 | 7 | 31 | 354 | - | 709 | 4,187 | 337 | 233 |